The all-virtual ACR Convergence 2020 experience includes the highest-quality educational content along with innovative session formats and multiple opportunities to network with colleagues. We invite you to explore The Rheumatologist’s complete coverage of the meeting. Plus, explore our resource centers focused on rheumatoid arthritis, systemic lupus erythematosus and gout, along with our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of these conditions.
Resource Centers
Systemic Lupus Erythematosus Resource Center
Watch this space for our coverage of systemic lupus erythematosus (SLE) sessions at ACR Convergence 2020, beginning with a report on the State of the Art: Lupus—the Future Is Now session, moderated by Saira Sheikh, MD. Plus, explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of SLE.
VIEWRheumatoid Arthritis Resource Center
The Great Debate at ACR Convergence 2020 is: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA. No need to hang in suspense. In this resource center, you’ll get the pros and cons, and highlights from other important sessions on rheumatoid arthritis (RA). Plus, you can explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA.
VIEWGout Resource Center
Earlier this year, the ACR released a new guideline for the management of gout, leaving some rheumatologists unsure what to recommend to their patients. Clearing up the confusion is one aim of the session, Evidence-Based Guidance for Optimizing Gout Management. Learn what the experts recommend and explore our coverage of additional gout information presented at ACR Convergence 2020, plus our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout.
VIEW
Complete Convergence Coverage
ACR Convergence 2020 Workshop Covers 2021 Practice Management & Coding Changes
Attendees at the daylong workshop will learn about key evaluation and management code changes coming in 2021 that affect rheumatologists and rheumatology professionals.... [Read More]
Bring Quality Measures into Focus at ACR Convergence 2020
A panel of rheumatologists will provide updates on MACRA’s quality measure requirements and the ACR’s progress in quality measurement in rheumatology in a session at ACR Convergence 2020.... [Read More]
Pregnancy Complications in Patients with Lupus & APS
Pregnancy complications are common in lupus and antiphospholipid syndrome (APS), but can we predict and prevent them? The Rheumatology Research Foundation Memorial Lectureship to Honor Shaun Ruddy, MD, will review the predictors and mechanisms of pregnancy complications, as well as potential interventions for preventing pregnancy complications associated with lupus and APS. Watch for it on… [Read More]
Lupus Nephritis: New Decade, New Approaches
This session at ACR Convergence will focus on early biomarkers for diagnostic and prognostic purposes, as well as the description of current treatment guidelines from multiple societies. The speakers will discuss the role of repeated biopsy to assess response and maintenance therapy, and describe some promising new therapies under development. Watch for it on Sunday,… [Read More]
The Great Debate at ACR Convergence 2020: Should Jakinibs Be Used Before Biologics for RA?
The 2015 ACR guideline for RA treatment specifies that TNF inhibitors should be used before JAK inhibitors (jakinibs) for the treatment of RA when a patient fails to have an adequate response to conventional DMARDs. However, emerging data indicate that jakinibs may be even more effective than TNF inhibitors. Is it time to revisit this… [Read More]
Pain in RA and OA: ACR Convergence 2020 Preview
Patients with RA and OA have joint pain, and pain is the primary reason patients seek care. The mechanisms responsible for the pain are now just beginning to be understood. This session, on Nov. 6, 4 p.m. EST, will cover the mechanisms responsible for the development of pain in both inflammatory and degenerative arthritis.
Racial Disparity in RA & OA: ACR Convergence 2020 Preview
Minority race/ethnicity are associated with more severe outcomes in OA and RA. Although African Americans have more symptomatic RA than whites, they are more likely to delay seeking care and initiating DMARDs and biologics. The session on Nov. 6, 3 p.m. EST, will review current outcomes data for RA and OA, including TKA, THA and… [Read More]
State of the Art: Lupus—the Future Is Now
Sunday, Nov. 8, 2020, 10–11:00 a.m. EST: Several lupus trials this past year had positive results, bringing hope that new therapeutics may be available in the near future. This session will discuss how advances in our understanding of lupus pathogenesis have led to the development of different therapeutic strategies. Watch this page for our report… [Read More]
COVID-19, New Research & More: 2 Experts Discuss Scientific Advances in Rheumatology at ACR Convergence 2020
The Year in Review session during ACR Convergence 2020 will address advances in clinical and basic science related to rheumatology, including drug safety, precision medicine, the COVID-19 pandemic and more.... [Read More]
ACR Convergence Offers Quick Reviews of Rheumatology Topics in Shorter, ‘Down & Dirty 30’ Sessions
Here’s a taste of what participants in this year’s virtual annual meeting, ACR Convergence 2020, will have access to during Down & Dirty 30, four 30-minute sessions designed to provide refreshers on specific rheumatology-related topics.... [Read More]